Publication: Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?
Program
Authors
Authors
TARKUN, PINAR
Atalay, Figen
Atesoglu, Elif Birtas
Mehtap, Ozgur
Simsek, MELİH
Terzi, Esra
GEDÜK, AYFER
Balli, Fatih
Batman, Adnan
BAYDEMİR, CANAN
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
ObjectiveTwo-thirds of newly diagnosed patients with multiple myeloma (MM) are over 65yr and/or physically unfit. Such patients are not eligible for high-dose chemotherapy or stem cell transplantation. The treatment aims in these patients should be to prolong survival by obtaining the best possible response, while maintaining good tolerability. The aim of our study was to evaluate the response to treatment and treatment-related toxicities in patients treated with conventional and novel protocols.
Description
Source:
Keywords:
Keywords
Citation
TARKUN P., Atalay F., Atesoglu E. B. , Mehtap O., Simsek M., Terzi E., GEDÜK A., Balli F., Batman A., BAYDEMİR C., et al., -Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?-, EUROPEAN JOURNAL OF HAEMATOLOGY, cilt.94, sa.5, ss.424-430, 2015